These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25548784)

  • 81. Lupus nephritis, emphasizing tubulointerstitial lesions: a clinico-pathological analysis.
    Wei CH; Ho YS; Chou BL; Sheu LF; Shieh SD; Chen A; Tu YC
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 Jan; 51(1):27-32. PubMed ID: 8384052
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Lupus nephritis in the Western Cape, a high prevalence area: an experience over three decades.
    Brijlal U; Bates WD; Moosa MR
    Lupus; 2017 Oct; 26(11):1228-1234. PubMed ID: 28420052
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Intrarenal cytokine gene expression in lupus nephritis.
    Chan RW; Lai FM; Li EK; Tam LS; Chow KM; Lai KB; Li PK; Szeto CC
    Ann Rheum Dis; 2007 Jul; 66(7):886-92. PubMed ID: 17324967
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Significance of histological crescent formation in patients with diffuse proliferative lupus nephritis.
    Chen S; Tang Z; Zhang Y; Liu Z; Zhang H; Hu W; Liu Z
    Am J Nephrol; 2013; 38(6):445-52. PubMed ID: 24247741
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Correlation among WHO classes, histomorphologic patterns of glomerulonephritis and glomerular immune deposits in SLE.
    Ferluga D; Jerse M; Vizjak A; Hvala A; Rozman B; Kos-Golja M; Bren AF
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):692-701. PubMed ID: 11020959
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clinicopathological significance of tubulointerstitial CD68 macrophages in proliferative lupus nephritis.
    Chen J; Cui L; Ouyang J; Wang J; Xu W
    Clin Rheumatol; 2022 Sep; 41(9):2729-2736. PubMed ID: 35616755
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Treatment of lupus nephritis.
    Dolff S; Berden JH; Bijl M
    Expert Rev Clin Immunol; 2010 Nov; 6(6):901-11. PubMed ID: 20979555
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Predominant tubulointerstitial lupus nephritis.
    Singh AK; Ucci A; Madias NE
    Am J Kidney Dis; 1996 Feb; 27(2):273-8. PubMed ID: 8659506
    [TBL] [Abstract][Full Text] [Related]  

  • 89. New subcategories of class IV lupus nephritis: are there clinical, histologic, and outcome differences?
    Mittal B; Hurwitz S; Rennke H; Singh AK
    Am J Kidney Dis; 2004 Dec; 44(6):1050-9. PubMed ID: 15558526
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Pathological classification and clinical characteristics of lupus nephritis: a report of 49 cases].
    Liu Y; Yang HF; Wang LX
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1915-7. PubMed ID: 20813701
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Hematuria in a patient with class IV lupus nephritis.
    Mittal BV; Pendse S; Rennke HG; Singh AK
    Kidney Int; 2006 Sep; 70(6):1182-6. PubMed ID: 16871238
    [No Abstract]   [Full Text] [Related]  

  • 92. Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring.
    Hsieh C; Chang A; Brandt D; Guttikonda R; Utset TO; Clark MR
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):865-74. PubMed ID: 21309006
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Lupus nephritis: clinical presentations and outcomes in the 21st century.
    Gasparotto M; Gatto M; Binda V; Doria A; Moroni G
    Rheumatology (Oxford); 2020 Dec; 59(Suppl5):v39-v51. PubMed ID: 33280015
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Correlation of clinical and pathological findings in patients with lupus nephritis: a five-year experience in Iran.
    Nezhad ST; Sepaskhah R
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):32-40. PubMed ID: 18087120
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Worse renal outcome of subclass IV-G lupus nephritis patients over IV-S.
    Duque de Sá Carneiro Filho EJ; Jorge LB; Testagrossa L; Bitencourt C; Yu L; Woronik V
    Lupus; 2018 Apr; 27(4):584-590. PubMed ID: 28927317
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Lupus nephritis. Clinicopathological correlation.
    Al-Zahrani IH; Qayyum A
    Saudi Med J; 2007 Oct; 28(10):1503-5. PubMed ID: 17914508
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis.
    Cohen D; Koopmans M; Kremer Hovinga IC; Berger SP; Roos van Groningen M; Steup-Beekman GM; de Heer E; Bruijn JA; Bajema IM
    Arthritis Rheum; 2008 Aug; 58(8):2460-9. PubMed ID: 18668574
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Managing lupus nephritis: algorithms for conservative use of renal biopsy.
    Salach RH; Cash JM
    Cleve Clin J Med; 1996; 63(2):106-15. PubMed ID: 8819695
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Clinicopathological correlations and prognostic factors in lupus nephritis.
    Mitjavila F; Pac V; Moga I; Poveda R; Vidaller A; Carrera M; Pujol R
    Clin Exp Rheumatol; 1997; 15(6):625-31. PubMed ID: 9444418
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages.
    Hill GS; Delahousse M; Nochy D; Rémy P; Mignon F; Méry JP; Bariéty J
    Kidney Int; 2001 Jan; 59(1):304-16. PubMed ID: 11135084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.